Galderma has decided to target solely on dermatology, in creating modern treatment methods aimed towards the main ailments associated with the skin and offering thorough expertise to skin scientists. Each year around 20% of its revenue is allocated for developing brand new solutions and obtaining innovative technologies.
Over the past twenty years, these endeavours have led to granting of more than 5500 patents and about 1700 pharmaceutical drug registrations internationally in areas related to skin, hair, and nails.
A large number of the innovations in skin care are identified in the science labs of educational research institutions and in non-profit organizations around the world, therefore Galderma facilitates these studies by means of providing unlimited access to research grants.
In order to provide high quality products and services, the production functionality is extended across three different sites in the world.
The French site is located in Alby Sur Chéran and is manufacturing products in liquid forms with a capacity of 30 million units/year. The second site is based in Montreal, Canada and has an output of around 50 million units/year. Their pharmaceutical products are mainly distributed in the US. The Brazilian site Hortolândia is specialized in liquid and paste forms and its capacity reaches the 5 million mark. Their products are distributed throughout Brazil and South America.
The R&D departments are entirely focused on modern medical solutions for the dermatology markets and the departments are located in the US, Japan and France.
The Department in Sophia Antipolis, France is the largest facility in the globe, which focuses solely on dermatology sciences.

(Image: Galderma, France)
Around 500 hundred scientists and service personnel are employed at the Center with expertise beginning from genomics to proteomics, from chemistry and toxic-genomics to pharmacokinetics.
Based in New Jersey, United States, the Princeton Center is dedicated to medical development with the main goal of acquiring registration of the company's units in North America.

(Image: Galderma, USA)
The team in Tokyo, Japan is exclusively committed to the development and registration of brand new products for the Japanese market, the second biggest skin care marketplace worldwide.
There are different scientific and medical divisions existent at Galderma, some of them are outlined below:
The R&D Department is responsible for all research activities related to chemistry, biology, and pharmacological methods in order to find brand new lively molecules.
The Regulatory Affairs Department determines the methodological approach for all new products, and publishes application dossiers for every single country.
The Medical Department is in charge of the marketing, publications and scientific symposia. In addition, it deals with all the communications of the professional medical networks via congresses and the Web.
Pharmacovigilance Division makes sure that the advantage and risk equilibrium of formulated and advertised medicines is clearly perceived.
Professionals and Researchers with Medical, Biology, Chemistry, and Pharmaceutical Degrees are encouraged to apply.